Differences in immune-related semaphorin levels in the CSF and serum of newly diagnosed, treatment-naive patients with relapsing–remitting multiple sclerosis: a case–control study - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Variations in Immune-Associated Semaphorin Concentrations in Cerebrospinal Fluid and Serum of Newly Diagnosed, Untreated Patients with Relapsing-Remitting Multiple Sclerosis: A Case-Control Analysis

  • By

  • Furkan Sarıdaş

  • Birnur Aydın

  • Rifat Özpar

  • Emine Rabia Koç

  • Bahattin Hakyemez

  • Tülin Alkan

  • Ömer Faruk Turan

  • July 14, 2026

Share

Original Source(s)

Related Content